Last updated on August 2019

A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: NIDDM
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Participants must have T2D based on the disease diagnostic criteria World Health Organization (WHO) classification.
  • Participants must have been treated for at least 90 days prior to screening with either basal insulin + at least 1 prandial injection of bolus insulin or premixed analog/human insulin regimens at least twice daily.
  • Participants must be treated no more than 3 oral anti-hyperglycemic medications (OAMs).
  • Participants must have a HbA1c 7.0% and 11.0%.
  • Participants must have body mass index (BMI) of 35.0 kilograms per meter squared (kg/m2).

Exclusion Criteria:

  • Participants must not have been diagnosed, at any time, with type 1 diabetes (T1D) or latent autoimmune diabetes in adults.
  • Participants must not have had any episode of severe hypoglycemia within the 6 months prior to screening.
  • Participants must not have had 1 or more episodes of diabetic ketoacidosis or hyperglycemic hyperosmolar state within the 6 months prior to screening.
  • Participants must not have used thiazolidinediones, glucagon-like peptide 1 (GLP-1) receptor agonist, or pramlintide within 90 days prior to screening.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.